Pomdoctor Limited Pivots to AI + Medical-Grade Smart Wearables for Chronic Disease Management
ByAinvest
Friday, Mar 13, 2026 8:01 am ET1min read
POM--
Pomdoctor Limited, a leading online medical services platform in China, announces a strategic upgrade focused on AI + medical-grade smart wearables + full-cycle chronic disease management. The upgrade aims to build a closed-loop ecosystem integrating hardware, data, algorithms, and services, expanding its growth horizon while delivering sustained medical value to patients. The company plans to leverage its medical resources and compliance capabilities to accelerate technology R&D and scenario-based implementation, targeting the global chronic disease management market projected to grow at a CAGR of 11.7% from $6.9 billion in 2025 to $18.8 billion by 2034.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet